Filing Details

Accession Number:
0001127602-21-028992
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-11-12 16:42:44
Reporting Period:
2021-11-09
Accepted Time:
2021-11-12 16:42:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1140859 Amerisourcebergen Corp ABC Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122) 233079390
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1191508 H Steven Collis 1 West First Avenue
Conshohocken PA 19428
Chairman, President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-11-09 12,784 $98.24 197,363 No 4 M Direct
Common Stock Acquisiton 2021-11-09 11,480 $75.61 208,843 No 4 M Direct
Common Stock Disposition 2021-11-09 24,264 $125.33 184,579 No 4 S Direct
Common Stock Acquisiton 2021-11-10 12,718 $0.00 197,297 No 4 M Direct
Common Stock Disposition 2021-11-10 5,530 $125.68 191,767 No 4 F Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 F Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-qualified Stock Option (Right to Buy) Disposition 2021-11-09 11,480 $0.00 11,480 $75.61
Common Stock Non-qualified Stock Option (Right to Buy) Disposition 2021-11-09 12,784 $0.00 12,784 $98.24
Common Stock Restricted Stock Units Disposition 2021-11-10 12,718 $0.00 12,718 $0.00
Common Stock Restricted Stock Units Acquisiton 2021-11-10 35,806 $0.00 35,806 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
172,200 2023-11-09 No 4 M Direct
38,351 2022-11-11 No 4 M Direct
25,437 No 4 M Direct
35,806 No 4 A Direct
Footnotes
  1. Grant of restricted stock units received for no consideration that vest in three equal annual installments on 11/10/2021, 11/10/2022, and 11/10/2023.
  2. The sale of stock reflected in this Form 4 was affected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective 8/20/21 and disclosed in the Company's 8-K filed with the Securities and Exchange Commission on 8/26/21.
  3. Exercisable in four equal annual installments on 11/9/17, 11/9/18, 11/9/19 and 11/9/20.
  4. Exerciseable in four equal annual installments on 11/11/16, 11/11/17, 11/11/18 and 11/11/19.
  5. Grant of restricted stock units received for no consideration that vest in three equal annual installments on 11/10/2022, 11/10/2023, and 11/10/2024.